Resistance development in ART-naive patients randomized to receive immediate or extended release formulations of nevirapine (NVP) in combination with tenofovir (TDF) and emtricitabine (FTC): (VERxVE)
ANTIVIRAL THERAPY（2011）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要